Skip to main content
. 2020 May 8;12(5):434. doi: 10.3390/pharmaceutics12050434

Figure 8.

Figure 8

Lactoferrin contributes the renoprotective effect in the AKI to CKD transition. Lactoferrin induces autophagy through the activation of AMPK and inhibition of Akt/mTOR pathway in human kidney tubular epithelial cells. Furthermore, lactoferrin suppresses oxidative stress-induced apoptosis by augmenting autophagy. Lactoferrin restrains renal fibrosis. Therefore, lactoferrin is an effective therapeutic intervention for the AKI to CKD continuum.